CRISPR Therapeutics AG - Company Profile
Powered by 
All the data and insights you need on CRISPR Therapeutics AG in one report.
$295
- Save hours of research time and resources with
our up-to-date CRISPR Therapeutics AG Strategy Report
- Understand CRISPR Therapeutics AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on CRISPR Therapeutics AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into CRISPR Therapeutics AG's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Samarth Kulkarni
Chairman; Director; Chief Executive Officer Executive BoardMr. Samarth Kulkarni has been the Chairman of the company since 2023. He also serves as the Chief Executive Officer and Director of the company since 2017. Prior to this, he served as the Chief Business Officer at CRISPR from 2015 to 2017. Mr. Kulkarni also served as a Partner at McKinsey and Company. While at McKinsey, he co-led the biotech practice and served a number of biotechnology companies on topics ranging from strategy to operations.
Raju Prasad, Ph.D
Chief Financial Officer Senior ManagementMr. Raju Prasad, Ph.D has been the Chief Financial Officer of the company since March 2023. Prior to this, he served as a partner at William Blair & Company From March 2014 to 2023. Previously he served as University of North Carolina at Chapel Hill’s Gillings School of Global Public Health and U.S. Environmental Protection Agency.
Shelby Walker
Head - Intellectual Property Senior ManagementSteve Caffe
Head - Regulatory Affairs Senior ManagementAlex Harding, M.D., M.B.A
Head - Business Development Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer